Full title: Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Author/creator: on behalf of the ML18147 Study Investigators, ML18147 Study Investigators, Bennouna, Jaafar, MD, Sastre, Javier, MD, Arnold, Dirk, Prof, Österlund, Pia, MD, Greil, Richard, Prof, Van Cutsem, Eric, Prof, von Moos, Roger, MD, Viéitez, Jose Maria, MD, Bouché, Olivier, Prof, Borg, Christophe, MD, Steffens, Claus-Christoph, MD, Alonso-Orduña, Vicente, MD, Schlichting, Christoph, MD, Reyes-Rivera, Irmarie, MD, Bendahmane, Belguendouz, MD, André, Thierry, Prof, Kubicka, Stefan, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1266103920

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1266103920